Cardiol Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRDL and other ETFs, options, and stocks.About CRDL
Cardiol Therapeutics, Inc. is a clinical-stage life sciences company focused on the research and clinical of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases.
CEODavid G. Elsley
CEODavid G. Elsley
Employees22
Employees22
HeadquartersOakville, Ontario
HeadquartersOakville, Ontario
Founded2017
Founded2017
Employees22
Employees22
CRDL Key Statistics
Market cap107.50M
Market cap107.50M
Price-Earnings ratio-3.60
Price-Earnings ratio-3.60
Dividend yield—
Dividend yield—
Average volume955.75K
Average volume955.75K
High today$1.11
High today$1.11
Low today$1.06
Low today$1.06
Open price$1.11
Open price$1.11
Volume349.22K
Volume349.22K
52 Week high$1.59
52 Week high$1.59
52 Week low$0.7709
52 Week low$0.7709
Stock Snapshot
With a market cap of 107.5M, Cardiol Therapeutics(CRDL) trades at $1.08. The stock has a price-to-earnings ratio of -3.60.
During the trading session on 2025-12-13, Cardiol Therapeutics(CRDL) shares reached a daily high of $1.11 and a low of $1.06. At a current price of $1.08, the stock is +1.8% higher than the low and still -2.7% under the high.
Trading activity shows a volume of 349.22K, compared to an average daily volume of 955.75K.
Over the past 52 weeks, Cardiol Therapeutics(CRDL) stock has traded between a high of $1.59 and a low of $0.77.
Over the past 52 weeks, Cardiol Therapeutics(CRDL) stock has traded between a high of $1.59 and a low of $0.77.
People also own
Based on the portfolios of people who own CRDL. This list is generated using Robinhood data, and it’s not a recommendation.